Chronic pain

HEALTH INFORMATION

Home ❯ Chronic pain
Understanding how the brain is involved in chronic pain

WHAT WE KNOW

One in five Australians experience chronic pain that is serious enough to disable them, costing the country approximately $35 billion a year. People who experience chronic pain (pain that continues for more than three months) often struggle to find effective treatment, and can experience disability and even depression.

We are conducting research into the nature of chronic pain, looking at the role of our brain in the experience of persistent pain, and changes in the central nervous system that may also occur.

We are also investigating why some people develop excessive pain in response to injury, developing a disorder called Complex Regional Pain Syndrome.

More information

OUR LATEST RESEARCH

Medicines for Back Pain


MATTHEW BAGG, ASSOCIATE PROFESSOR JAMES MCAULEY, PAULINE ZAHARA, ANIKA HAIGH, EDEL O’HAGAN, AIDAN CASHIN, THIAGO FOLLY, DR MARKUS HUEBSCHER
Medicines are a common treatment for back pain. The aim of this program of research is to improve our understanding of the clinical effects of medicines. Several studies constitute this program. 
 
Studies: 
1. A scoping review of analgesic medicines for chronic low back pain
The objective of this study is to identify the available clinical trials of medicines for chronic low back pain.  
This information will contribute to the methodology of Study 3. 
 
2. Evaluation of the impact of unpublished data from clinical trial registries on the effects of medicines for low back pain. 
The objective of this study is to evaluate whether there is a difference between clinical trial data that are published and those that are not published. 
This information will contribute to the methodology of Study 3. 
 
3. Paracetamol, NSAIDs and opioid analgesics for chronic low back pain: a network meta-analysis. 
The objective of this study is to produce information about the clinical effects of available analgesic medicines for chronic low back pain. This information will be available in a Cochrane review to assist clinical prescription of medicines.

SLEEPAIN


ASSOCIATE PROFESSOR JAMES MCAULEY, DR SYLVIA GUSTIN, EDEL O’HAGAN

For people with back pain who are having trouble with their sleep. We are testing whether a simple sleep tablet will help people reduce their pain and sleep better.

RESOLVE - RECRUITING NOW


ASSOCIATE PROFESSOR JAMES MCAULEY, MATTHEW BAGG, DR SYLVIA GUSTIN

For people with long term back pain that is not getting better. We are testing two pain treatment programs that target the brain, for people with chronic low back pain.

PREVENT


ASSOCIATE PROFESSOR JAMES MCAULEY, DR SYLVIA GUSTIN, PROF LORIMER MOSELEY

For people with a new low back pain episode. We are testing early intervention to reduce the risk of developing chronic low back pain.

Identifying cortical and subcortical sites responsible for the divergent sympathetic responses to long-lasting muscle pain


PROF VAUGHAN MACEFIELD

We are trying to identify how a constant sensory input (muscle pain) causes two divergent patterns of sympathetic response: an increase in MSNA and blood pressure in some individuals and a decrease in others.

The effects of tonic muscle pain on the sympathetic and somatic motor systems


DR INGVARS BIRZNIEKS

Chronic pain, defined as pain lasting for >3 months, typically develops from injuries to deep tissues such as muscle, yet little is known about how long-lasting pain affects a person’s blood pressure or capacity to control their muscles. This project assesses the effects of tonic muscle pain on sympathetic nerve activity and stretch sensitivity of muscle spindles.

TEAM LEADERS IN CHRONIC PAIN

ASSOCIATE PROFESSOR JAMES MCAULEY Senior Research Scientist and Group Leader, NeuRA Associate Professor, Faculty of Medicine, UNSW Honorary Research Fellow, The George Institute for Global Health

PROF LORIMER MOSELEY Senior Principal Research Fellow, NeuRA NHMRC Principal Research Fellow Professor of Clinical Neurosciences & Foundation Chair in Physiotherapy, University of South Australia

What else is happening in Chronic pain research at NeuRA?

FEEL THE BUZZ IN THE AIR? US TOO.

Associate Professor Kim Delbaere on Australian Chiropractor's Association podcast

Associate Professor James McAuley, says the Australian Government’s Therapeutic Goods Administration’s rescheduling of over the counter opioids is a positive step in curbing opioid addiction, but it is now more important than ever for clinicians and patients to be aware of opioid-free treatment options for chronic pain. “Drugs are a great solution to pain for the first one to two […]

James McAuley
NeuRA BLOG: Pain free and drug free

You can help change our nations mental health outlook

Australia, the lucky country... with good employment prospects, a high standard of living, wonderful health care and beaches, bush, and landscapes the envy of the world. However Australia’s poor mental health is a national health crisis that demands our attention. We have the second highest incidence of depression in the world Nearly 3.5 million Australians suffer from a form of anxiety The leading cause of death in individuals aged 15 to 44 is suicide, with young tradesmen 70% more likely to take their own lives than males employed in other industries. We are losing too many spirited and warm people to suicide and depression, watching families torn apart by chronic anxiety and lives severely affected by conditions like schizophrenia and bipolar disorder. Please support mental health research at NeuRA Will you help NeuRA invest in mental health research, with a gift today? Or perhaps you’d like to become a Discovery Partner, and give a small amount monthly? Mental health research at NeuRA is growing, and there is some exciting breakthroughs on the horizon. I invite you to give today, and become a partner in those breakthroughs. Thank you for your support.
APPEAL
Free dementia seminar - Central Coast
Hypnosis transforming chronic pain treatment

Medicines for Back Pain

Medicines are a common treatment for back pain. The aim of this program of research is to improve our understanding of the clinical effects of medicines. Several studies constitute this program.    Studies:  1. A scoping review of analgesic medicines for chronic low back pain The objective of this study is to identify the available clinical trials of medicines for chronic low back pain.   This information will contribute to the methodology of Study 3.    2. Evaluation of the impact of unpublished data from clinical trial registries on the effects of medicines for low back pain.  The objective of this study is to evaluate whether there is a difference between clinical trial data that are published and those that are not published.  This information will contribute to the methodology of Study 3.    3. Paracetamol, NSAIDs and opioid analgesics for chronic low back pain: a network meta-analysis.  The objective of this study is to produce information about the clinical effects of available analgesic medicines for chronic low back pain. This information will be available in a Cochrane review to assist clinical prescription of medicines.
PROJECT
VOLUNTEER
SUPPORT OUR RESEARCH
STUDENTS
CAREERS